Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2016 1
2019 1
2020 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Compounding in Nigeria.
Alfred-Ugbenbo D, Zdoryk OA, Georgiyants VA, Schnatz R. Alfred-Ugbenbo D, et al. Among authors: georgiyants va. Int J Pharm Compd. 2016 May-Jun;20(3):189-192. Int J Pharm Compd. 2016. PMID: 28333658
Compounding in Ukraine.
Zdoryk OA, Georgiyants VA, Gryzodub OI, Schnatz R. Zdoryk OA, et al. Among authors: georgiyants va. Int J Pharm Compd. 2013 Mar-Apr;17(2):124-7. Int J Pharm Compd. 2013. PMID: 23696172
Synthesis, analysis of mol-ecular and crystal structures, estimation of inter-molecular inter-actions and biological properties of 1-benzyl-6-fluoro-3-[5-(4-methylcyclohexyl)-1,2,4-oxadiazol-3-yl]-7-(piperidin-1-yl)quinolin-4-one.
Vaksler Y, Hryhoriv HV, Ivanov VV, Kovalenko SM, Georgiyants VA, Langer T. Vaksler Y, et al. Among authors: georgiyants va. Acta Crystallogr E Crystallogr Commun. 2023 Feb 21;79(Pt 3):192-200. doi: 10.1107/S2056989023001305. eCollection 2023 Feb 1. Acta Crystallogr E Crystallogr Commun. 2023. PMID: 36910005 Free PMC article.
Synthesis, docking, and biological evaluation of novel 1-benzyl-4-(4-(R)-5-sulfonylidene-4,5-dihydro-1H-1,2,4-triazol-3-yl)pyrrolidin-2-ones as potential nootropic agents.
Semenets AP, Suleiman MM, Fedosov AI, Shtrygol SY, Havrylov IO, Mishchenko MV, Kovalenko SM, Georgiyants VA, Perekhoda LO. Semenets AP, et al. Among authors: georgiyants va. Eur J Med Chem. 2022 Dec 15;244:114823. doi: 10.1016/j.ejmech.2022.114823. Epub 2022 Oct 7. Eur J Med Chem. 2022. PMID: 36274278
Synthesis, X-ray diffraction study, analysis of inter-molecular inter-actions and mol-ecular docking of ethyl 1-(3-tosyl-quinolin-4-yl)piperidine-4-carboxyl-ate.
Vaksler Y, Hryhoriv HV, Kovalenko SM, Perekhoda LO, Georgiyants VA. Vaksler Y, et al. Among authors: georgiyants va. Acta Crystallogr E Crystallogr Commun. 2022 Aug 9;78(Pt 9):890-896. doi: 10.1107/S2056989022007691. eCollection 2022 Sep 1. Acta Crystallogr E Crystallogr Commun. 2022. PMID: 36072518 Free PMC article.
Synthesis, in vivo and in silico anticonvulsant activity studies of new derivatives of 2-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)acetamide.
El Kayal WM, Shtrygol SY, Zalevskyi SV, Shark AA, Tsyvunin VV, Kovalenko SM, Bunyatyan ND, Perekhoda LO, Severina HI, Georgiyants VA. El Kayal WM, et al. Among authors: georgiyants va. Eur J Med Chem. 2019 Oct 15;180:134-142. doi: 10.1016/j.ejmech.2019.06.085. Epub 2019 Jul 2. Eur J Med Chem. 2019. PMID: 31302446